Technology Won’t “Save” Healthcare
Health technologies can reduce healthcare spending. On average, they don’t. Prominent examples—like the way polio vaccines eliminated the need for iron lungs—seem to drive a common faith in healthcare...
View ArticleHealth Technology Assessment: Global Advocacy and Local Realities
Cost-effectiveness analysis (CEA) can help countries attain and sustain universal health coverage (UHC), as long as it is context-specific and considered within deliberative processes at the country...
View ArticleBenefits and Universal Health Coverage: What Public Money Can Buy Given...
Here in the US, the Congress is wrestling with proposals to replace the Obama-era health reform. One strategy on the table is to modify the benefits that are legally required to be included in health...
View ArticleComments Needed: A Better Deal to Protect Americans’ Health under the Trump...
We would argue that investing in global health, at least along certain dimensions, is entirely consistent with President Trump’s philosophy of America First—a real opportunity for his administration to...
View ArticleThe Bad News Is Good News? The Problems of Graduating from Foreign Health Aid
Last month I attended a working group set up under the auspices of UHC2030 to look at the problems facing countries that lose external funding for their health programs. For many countries, the bad...
View ArticleWomen’s Economic Empowerment Means Access to Family Planning Too
There is one intervention omitted from Ivanka and Jim’s must-do list: access to family planning as a pre-requisite and enabler of women’s economic empowerment.Blog: Global Health Policy BlogAuthor(s):...
View ArticleTobacco Taxes Need to Be a Much Bigger Part of the Fiscal Policy Discussion
Why aren't tobacco taxes being addressed more forcefully and in more countries? Evidence suggests that tobacco taxes can be extremely effective—the cost is very low relative to the revenues and fully...
View ArticleThe World’s Most Profitable Slow-Motion Disaster: Tobacco
In April, I attended a very hopeful event sponsored by the World Bank entitled, “Tobacco Taxation Win-Win for Public Health and Domestic Resources Mobilization.” My optimism was buoyed by seeing people...
View ArticleWhere Does WHO Get Its Economic Advice?
As a new WHO Director-General—Dr. Tedros Adhanom Ghebreyesus—prepares to take office, many have called for clearer priorities, governance and organizational reforms, and funding expansions. All good,...
View ArticleWhere Does WHO Get Its Economic Advice? – Part Two
My recent blog post on economics at WHO alongside Tony Culyer’s open letter to incoming Director-General Dr. Tedros generated great feedback and discussion. Below, you can find my views on some of the...
View ArticleOnwards and Upwards: Strengthening Global Cooperation to Address...
Without global action, by 2050 there could be as many as 10 million antimicrobial resistance-related deaths each year. An important—and often overlooked—part of the problem is the overuse of...
View ArticleFamily Planning Summit Raises Much-Needed Funds. Now It’s Time for Donors to...
With significant new money raised for the cause of family planning—an important accomplishment given the uncertainty around sustained US funding and the reinstatement of the Mexico City Policy—it’s now...
View ArticleWelcome Dr Kalipso Chalkidou—CGD’s New Director of Global Health Policy
I am delighted to welcome Dr. Kalipso Chalkidou as the new director of CGD’s Global Health Policy program and a CGD senior fellow. With a wealth of frontline policy experience, academic credentials and...
View ArticleThe Changing Landscape of Global Health Procurement: Acting Now to Prepare...
Health products—including drugs, devices, diagnostics, and vector control tools—are essential for meeting the healthcare needs of any population. Right now, many low- and lower-middle-income countries...
View ArticleIs UK Aid Being Spent Properly? We Just Don’t Know
In late July, the UK’s National Audit Office (NAO) published a progress report on Her Majesty’s Government spending that found that in 2015, a fifth of the £12.1 billion the country spent on aid was...
View ArticleTobacco Companies Fail the Corporate Social Responsibility Test of a...
Philip Morris International and other cigarette manufacturers are among the most profitable firms in the world, selling the world’s most lethal legal product. They prominently advertise their...
View ArticleTaking Stock of Aid Agency Evaluations in Global Health: Here’s What We Know...
With the US Congress considering cuts to foreign assistance and aid budgets in other donor countries coming under increased pressure, evidence about what works in global development is more important...
View ArticleResearch in the Time of Ebola: How We Can Do Better
The 2014-2015 Ebola outbreak in West Africa was a disturbing demonstration of the inadequacy of international institutions to assist the affected peoples or learn how to better treat and prevent their...
View ArticleRigorous Evidence Shows US Global Health Efforts Work. Come Hear About It at...
Clear and rigorous evidence on the contributions of US global health programs is more important than ever, as the White House and lawmakers discuss and debate budgets and the future of US support to...
View ArticleWHO’s Draft Concept Note: Treating the Symptoms, Not the Causes?
Global health policy enthusiasts will be excited to see that WHO has recently published a draft Concept Note on the 2019-2013 Programme of Work under the stewardship of its new Director-General. We see...
View Article